Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
28.80
+0.98 (3.52%)
At close: Feb 18, 2026, 4:00 PM EST
28.89
+0.09 (0.31%)
After-hours: Feb 18, 2026, 4:10 PM EST

Assembly Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
4561005463112200
Market Cap Growth
411.26%85.89%-14.91%-43.14%-44.18%-69.80%
Enterprise Value
22279-41-71-27
Last Close Price
27.8215.789.8415.6027.9672.60
PS Ratio
12.143.527.53-17.832.53
PB Ratio
2.413.011.310.770.660.83
P/TBV Ratio
2.473.011.310.770.661.00
P/FCF Ratio
--2.40---
P/OCF Ratio
--2.37---
EV/Sales Ratio
5.960.241.21---
EV/FCF Ratio
--0.39---
Debt / Equity Ratio
0.020.090.060.040.040.04
Debt / FCF Ratio
--0.10---
Net Debt / Equity Ratio
-1.26-3.27-3.11-1.07-0.99-0.86
Net Debt / EBITDA Ratio
5.312.411.990.951.833.53
Net Debt / FCF Ratio
4.122.13-5.691.041.743.25
Asset Turnover
0.220.220.06-0.030.25
Quick Ratio
4.392.353.335.709.148.91
Current Ratio
4.442.423.415.959.599.19
Return on Equity (ROE)
-36.94%-107.92%-98.95%-74.00%-63.42%-24.19%
Return on Assets (ROA)
-15.96%-22.18%-33.87%-39.70%-24.35%-11.85%
Return on Capital Employed (ROCE)
-23.30%-63.60%-66.20%-108.80%-52.80%-22.80%
Earnings Yield
-8.54%-40.06%-113.47%-146.80%-116.44%-31.11%
FCF Yield
-12.36%-50.99%41.68%-133.35%-86.53%-31.75%
Buyback Yield / Dilution
-51.02%-31.18%-13.47%-11.85%-22.17%-34.91%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q